Prevalence of the most common high-risk HPV genotypes among women in three new independent states of the former soviet union

Journal of Medical Virology

Volumn 79, Issue 6, 2007, Pages 771-781

  Kulmala, Satu Maria A ^a,b   Shabalova, Irena P ^c   Petrovitchev, Nikolay ^c   Syrjänen, Kari J ^d   Gyllensten, Ulf B ^e   Syrjänen, Stina M ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c N N BLOKHIN RUSSIAN CANCER RESEARCH CENTER   (Russian Federation)

^d TURKU UNIVERSITY HOSPITAL   (Finland)

^e UPPSALA UNIVERSITY   (Sweden)

Author keywords

Cervical cancer; High risk HPV; Type distribution; Viral load

Indexed keywords

VIRUS DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; CYTOLOGY; DNA DETERMINATION; FEMALE; GENOTYPE; GEOGRAPHIC DISTRIBUTION; GYNECOLOGIC DISEASE; HIGH RISK POPULATION; HUMAN; LATVIA; MAJOR CLINICAL STUDY; PREVALENCE; REAL TIME POLYMERASE CHAIN REACTION; SCREENING; SEXUALLY TRANSMITTED DISEASE; USSR; UTERINE CERVIX CARCINOMA IN SITU; VIRUS DETECTION; VIRUS LOAD; WART VIRUS;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BYELARUS; CERVIX UTERI; DNA, VIRAL; FEMALE; GENOTYPE; HUMANS; LATVIA; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PREVALENCE; RUSSIA; STATISTICS; UTERINE CERVICAL DYSPLASIA; VAGINAL SMEARS; VIRAL LOAD;

HUMAN PAPILLOMAVIRUS;

EID: 34248177481     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.20839     Document Type: Article

References (39)

1. Abba MC, Mauron SA, Gomez MA, Dulout FN, Golijow CD. 2003. Association of human papillomavirus viral load with HPV16 and high-grade intraepithelial lesion. Int J Gynecol Cancer 13:154-158.
2. Alexandrova YN, Lyshchov AA, Safronnikova NR, Imyanitov EN, Hanson KP. 1999. Features of HPV infection among the healthy attendants of gynecological practice in St. Petersburg, Russia. Cancer Lett 145:43-48.
3. Andersson S, Safari H, Mints M, Lewnsohn-Fuchs I, Gyllensten U, Johanson B. 2005. Type distribution, viral load and integration status of high-risk human papillomaviruses in pre-stages of cervical cancer (CIN). Br J Cancer 92:2195-2200.
4. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R, Shah KV. 1995. Prevalence of human papillomavirus in cervical cancer: A worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 87:796-802.
5. Bosch FX, de Sanjose S. 2003. Chapter 1: Human papillomavirus and cervical cancer-burden and assessment of causality. J Natl Cancer Inst Monogr 31:3-13.
6. Brown DR, Legge D, Qadadri B. 2002. Distribution of human papillomavirus types in cervicovaginal washings from women evaluated in a sexually transmitted diseases clinic. Sex Transm Dis 29:763-768.
7. Castle PE, Schiffman M, Herrero R, Hildesheim A, Rodriguez AC, Bratti MC, Sherman ME, Wacholder S, Tarone R, Burk RD. 2005. A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica. J Infect Dis 191:1808-1816.
8. Chaturvedi AK, Dumestre J, Gaffga AM, Mire KM, Clark RA, Braly PS, Dunlap K, Beckel TE, Hammons AF, Kissinger PJ, Hagensee ME. 2005. Prevalence of human papillomavirus genotypes in women from three clinical settings. J Med Virol 75:105-113.
9. Clifford GM, Gallus S, Herrero R, Munoz N, Snijders PJ, Vaccarella S, Anh PT, Ferreccio C, Hieu NT, Matos E, Molano M, Rajkumar R, Ronco G, de Sanjose S, Shin HR, Sukvirach S, Thomas JO, Tunsakul S, Meijer CJ, Franceschi S. 2005. IARC HPV Prevalence Surveys Study Group. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: A pooled analysis. Lancet 366:991-998.
10. de Villiers EM, Fauquet C, Broker T, Bernard HU, zur Hausen H. 2004. Classification of papillomaviruses. Virology 324:17-27.
11. Fife KH, Cramer HM, Schroeder JM, Brown DR. 2001. Detection of multiple human papillomavirus types in the lower genital tract correlates with cervical dysplasia. J Med Virol 64:550-559.
12. Herrero R, Hildesheim A, Bratti C, Sherman ME, Hutchinson M, Morales J, Balmaceda I, Greenberg MD, Alfaro M, Burk RD, Wacholder S, Plummer M, Schiffman M. 2000. Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst 92:464-474.
13. Ho GY, Kadish AS, Burk RD, Basu J, Palan PR, Mikhail M, Romney SL. 1998. HPV 16 and cigarette smoking as risk factors for high-grade cervical intra-epithelial neoplasia. Int J Cancer 78:281-285.
14. Josefsson AM, Magnusson PK, Ylitalo N, Sorensen P, Qwarforth-Tubbin P, Andersen PK, Melbye M, Adami HO, Gyllensten UB. 2000. Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: A nested case-control study. Lancet 355:2189-2193.
15. Kulmala SM, Syrjänen S, Shabalova I, Petrovichev N, Kozachenko V, Podistov J, Ivanchenko O, Zakharenko S, Nerovjna R, Kljukina L, Branovskaja M, Grujnberga V, Juschenko A, Tosi P, Santopietro R, Syrjänen K. and the NIS Cohort Study Group. 2004. Human papillomavirus testing with the hybrid capture 2 assay and PCR as screening tools. J Clin Microbiol 42:2470-2475.
16. Melkert PW, Hopman E, van den Brule AJ, Risse EKP, van Diest J, Bleker OP, Helmerhorst T, Schipper ME, Meijer CJ, Walboomers JM. 1993. Prevalence of HPV in cytomorphologically normal cervical smears, as determined by the polymerase chain reaction, is age-dependent. Int J Cancer 53:919-923.
17. Miller SA, Dykes DD, Polesky HF. 1988. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215.
18. Moberg M, Gustavsson I, Gyllensten U. 2003. Real-time PCR-based system for quantification of Human Papillomavirus types associated with high risk of cervical cancer. J Clin Microbiol 41:3221-3228.
19. Moberg M, Gustavsson I, Gyllensten U. 2004. Type-specific associations of human papillomavirus load with risk of developing cervical carcinoma in situ. Int J Cancer 112:854-859.
20. Moberg M, Gustavsson I, Gyllensten U. 2005. High viral loads of human papillomavirus predict risk of invasive cervical carcinoma. Br J Cancer 92:891-894.
21. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJ, Meijer CJ, 2003. International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348:518-527.
22. Munoz N, Bosch FX, Castellsague X, Diaz M, de Sanjose S, Hammouda D, Shah KV, Meijer CJ. 2004. Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer 111:278-285.
23. Qu W, Jiang G, Cruz Y, Chang CJ, Ho GY, Klein RS, Burk RD. 1997. PCR detection of human papillomavirus: Comparison between MY09/MY11 and GP5+/GP6+ primer systems. J Clin Microbiol 35:1304-1310.
24. Santos CN, Munoz S, Klug M, Almonte I, Guerrero M, Alvarez C, Velarde O, Galdos M, Castillo J, Walboomers C, Meijer E, Caceres E. 2001. HPV types and cofactors causing cervical cancer in Peru. Br J Cancer 85:966-967.
25. Sherman ME, Lorincz AT, Scott DR, Wacholder S, Castle PE, Glass AG, Mielzynska-Lohnas I, Rush BB, Schiffman M. 2003. Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: A 10-year cohort analysis. J Natl Cancer Inst 95:46-52.
26. Smith EM, Johnson SR, Ritchie JM, Feddersen D, Wang D, Turek LP, Haugen TH. 2004. Persistent HPV infection in postmenopausal age women. Int J Gynaecol Obstet 87:131-137.
27. Snijders PJ, Hogewoning CJ, Hesselink AT, Berkhof J, Voorhorst FJ, Bleeker MC, Meijer CJ. 2006. Determination of viral load thresholds in cervical scrapings to rule out CIN 3 in HPV 16, 18, 31 and 33-positive women with normal cytology. Int J Cancer 119:1102-1107.
28. Swan DC, Tucker RA, Tortolero-Luna G, Mitchell MF, Wideroff L, Unger ER, Nisenbaum RA, Reeves WC, Icenogle JP. 1999. Human papillomavirus (HPV) DNA copy number is dependent on grade of cervical disease and HPV type. J Clin Microbiol 37:1030-1034.
29. Syrjänen S, Shabalova I, Petrovichev N, Kozachenko V, Zakharova T, Pajanidi J, Podistov J, Chemeris G, Sozaeva L, Lipova E, Tsidaeva I, Ivanchenko O, Pshepurko A, Zakharenko S, Nerovjna R, Kljukina L, Erokhina O, Branovskaja M, Nikitina M, Grujnberga V, Grujnberg A, Juschenko A, Tosi P, Cintorino M, Santopietro R, Syrjänen K. 2002. Human papillomavirus testing and conventional pap smear cytology as optional screening tools of women at different risks for cervical cancer in the countries of the former soviet union. J Lower Genital Tract Dis 6:97-110.
30. Syrjänen S, Shabalova I, Petrovichev N, Kozachenko V, Zakharova T, Pajanidi J, Podistov J, Chemeris G, Sozaeva L, Lipova E, Tsidaeva I, Ivanchenko O, Pshepurko A, Zakharenko S, Nerovjna R, Kljukina L, Erokhina O, Branovskaja M, Nikitina M, Grujnberga V, Grujnberg A, Juschenko A, Johansson B, Tosi P, Cintorino M, Santopietro R, Syrjänen K. 2003. Sexual habits and human papillomavirus infection among females in three new independent states of the former Soviet Union. Sex Trans Dis 30:680-684.
31. Syrjänen S, Shabalova I, Petrovichev N, Kozachenko V, Zakharova T, Pajanidi J, Podistov J, Chemeris G, Sozaeva L, Lipova E, Tsidaeva I, Ivanchenko O, Pshepurko A, Zakharenko S, Nerovjna R, Kljukina L, Erokhina O, Branovskaja M, Nikitina M, Grujnberga V, Grujnberg A, Juschenko A, Tosi P, Cintorino M, Santopietro R, Syrjänen K. 2004. Acquisition of high-risk human papillomavirus infections and pap smear abnormalities among women in the New Independent States of the former Soviet Union. J Clin Microbiol 42:505-511.
32. Syrjänen K, Naud P, Derchain S, Roteli-Martins C, Longatto-Filho A, Tatti S, Branca M, Erzen M, Hammes LS, Matos J, Gontijo R, Sarian L, Braganca J, Arlindo FC, Maeda MY, Lorincz A, Dores GB, Costa S, Syrjänen S. 2005. Comparing PAP smear cytology, aided visual inspection, screening colposcopy, cervicography and HPV testing as optional screening tools in Latin America. Study design and baseline data of the LAMS study. Anticancer Res 25:3469-3480.
33. Syrjänen S, Shabalova I, Petrovichev N, Kozachenko V, Zakharova T, Pajanidi J, Podistov J, Chemeris G, Sozaeva L, Lipova E, Tsidaeva I, Ivanchenko O, Pshepurko A, Zakharenko S, Nerovjna R, Kljukina L, Erokhina O, Branovskaja M, Nikitina M, Grujnberga V, Grujnberg A, Juschenko A, Tosi P, Cintorino M, Santopietro R, Syrjänen K. 2005. Clearance of high-risk human papillomavirus (HPV) DNA and PAP smear abnormalities in a cohort of women subjected to HPV screening in the new Independent States of the former Soviet union (the NIS cohort study). Eur J Obstet Gynecol Reprod Biol 119:219-227.
34. Syrjänen S, Shabalova I, Petrovichev N, Kozachenko V, Zakharova T, Pajanidi J, Podistov J, Chemeris G, Sozaeva L, Lipova E, Tsidaeva I, Ivanchenko O, Pshepurko A, Zakharenko S, Nerovjna R, Kljukina L, Erokhina O, Branovskaja M, Nikitina M, Grujnberga V, Grujnberg A, Juschenko A, Cintorino M, Santopietro R, Tosi P, Syrjänen K. 2005. Factors predicting persistence of high-risk human papillomavirus (HPV) infections in women prospectively followed-up in three New Independent States (NIS) of the former Soviet Union. Eur J Gynaecol Oncol 26:491-498.
35. van Muyden RC, ter Harmsel BW, Smedts FM, Hermans J, Kuijpers JC, Raikhlin NT, Petrov S, Lebedev A, Ramaekers FC, Trimbos JB, Kleter B, Quint WG. 1999. Detection and typing of human papillomavirus in cervical carcinomas in Russian women: A prognostic study. Cancer 85:2011-2016.
36. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N. 1999. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:12-19.
37. Wu Y, Chen Y, Li L, Yu G, Zhang Y, He Y. 2006. Associations of high-risk HPV types and viral load with cervical cancer in China. J Clin Virol 35:264-269.
38. Ylitalo N, Sorensen P, Josefsson AM, Magnusson PK, Andersen PK, Ponten J, Adami HO, Gyllensten UB, Melbye M. 2000. Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: A nested case-control study. Lancet 355:2194-2198.
39. zur Hausen H. 2000. Papillomaviruses causing cancer: Evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst 92:690-698.